Antibe Therapeutics

(ATBPF)

By |

Profile

Antibe Therapeutics Inc develops safer, non-addictive medicines for pain and inflammation. Its technology involves linking a hydrogen sulfide-releasing molecule to an existing drug to produce an improved and patented medicine. The company's drug, ATB-346, targets the global need for a safer, non-addictive drug for chronic pain and inflammation. ATB-352, the second drug in pipeline, targets the urgent global need for a non-addictive analgesic for treating severe acute pain, while ATB-340 is a GI-safe derivative of aspirin. Its operating segment includes Antibe and Citagenix. The company generates maximum revenue from Citagenix segment and geographically from Canada. Citagenix segment is a marketer and distributor of regenerative medicines serving the dental and orthopaedic market places.

Contact Information

Website: www.antibethera.com
Main Phone: +1 416 922-3460
Address: 15 Prince Arthur Avenue
State: ON
City / Town: Toronto
Country: CA
Postal Code: M5R 1B2

Issuer Information

Exchange: OTCQB
CEO: Daniel Legault
Employees: 44
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Antibe Therapeutics Inc develops safer, non-addictive medicines for pain and inflammation. Its technology involves linking a hydrogen sulfide-releasing molecule to an existing drug to produce an improved and patented medicine. The company's drug, ATB-346, targets the global need for a safer, non-addictive drug for chronic pain and inflammation. ATB-352, the second drug in pipeline, targets the urgent global need for a non-addictive analgesic for treating severe acute pain, while ATB-340 is a GI-safe derivative of aspirin. Its operating segment includes Antibe and Citagenix. The company generates maximum revenue from Citagenix segment and geographically from Canada. Citagenix segment is a marketer and distributor of regenerative medicines serving the dental and orthopaedic market places.

Contact Information

Website: www.antibethera.com
Main Phone: +1 416 922-3460
Address: 15 Prince Arthur Avenue
State: ON
City / Town: Toronto
Country: CA
Postal Code: M5R 1B2

Issuer Information

Exchange: OTCQB
CEO: Daniel Legault
Employees: 44
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 0.28 $ -0.0008 (-0.29%)
Last Price 0.28 Change $ -0.0008 Change % -0.29 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 0.28 High 0.28 Low 0.27 Prev Close 0.28
Last Trade Volume 219,065 52 Wk Hi 0.65 52 Wk Low 0.28
Market Cap 106.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 385,516,301.00 EPS (TTM) -0.03 PE Ratio N/A Exchange OTCQB